Wonbiogen Co., Ltd. (KOSDAQ: 307280)
1,355.00
-15.00 (-1.09%)
Sep 11, 2024, 3:00 PM KST
Wonbiogen Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 3,375 | 3,036 | 3,226 | 7,671 | 1,126 |
Short-Term Investments | 7,771 | 5,520 | 5,347 | 6,087 | 124.02 |
Cash & Short-Term Investments | 12,544 | 8,556 | 8,573 | 13,758 | 1,250 |
Cash Growth | 21.09% | -0.19% | -37.69% | 1000.25% | - |
Accounts Receivable | 4,861 | 4,939 | 3,181 | 3,545 | 3,801 |
Other Receivables | 121.13 | 79.55 | 164.73 | 293.1 | - |
Receivables | 5,067 | 5,241 | 3,346 | 3,838 | 3,801 |
Inventory | 6,343 | 7,064 | 5,849 | 4,912 | 1,971 |
Prepaid Expenses | 75.32 | 84.99 | 94.78 | 82.43 | 36.4 |
Other Current Assets | 201.89 | 191.52 | 341.28 | 298.52 | 72.43 |
Total Current Assets | 24,231 | 21,138 | 18,204 | 22,889 | 7,132 |
Property, Plant & Equipment | 17,436 | 17,711 | 17,268 | 11,688 | 9,657 |
Long-Term Investments | 595.76 | 1,978 | 1,454 | 1,550 | - |
Goodwill | 510.41 | 510.41 | 510.41 | 510.41 | - |
Other Intangible Assets | 417.97 | 444.29 | 424.72 | 418.21 | 444.66 |
Long-Term Deferred Tax Assets | 328.03 | 323.54 | 323.2 | 155.28 | 237.03 |
Other Long-Term Assets | 740.82 | 798.14 | 748.16 | 832.77 | 1,805 |
Total Assets | 44,260 | 42,903 | 38,933 | 38,043 | 19,276 |
Accounts Payable | 797.33 | 696.58 | 721.73 | 1,036 | 266.42 |
Accrued Expenses | 444.35 | 385.17 | 364.73 | 304.69 | 224.3 |
Short-Term Debt | 5,800 | 6,300 | 8,700 | 7,494 | 1,000 |
Current Portion of Long-Term Debt | 50 | 59.99 | 48.27 | 73.2 | - |
Current Portion of Leases | 239.29 | 268.28 | 198.62 | 195.88 | 82.77 |
Current Income Taxes Payable | 657.53 | 852.76 | 704.54 | 2.98 | 147.74 |
Current Unearned Revenue | 33.4 | 37.88 | 14.76 | 61.21 | - |
Other Current Liabilities | 837.14 | 746.66 | 829.89 | 1,731 | 15,413 |
Total Current Liabilities | 8,859 | 9,347 | 11,583 | 10,899 | 17,134 |
Long-Term Debt | 391.67 | 416.67 | 9.99 | 58.26 | 1,532 |
Long-Term Leases | 186.1 | 272.84 | 244.29 | 267.51 | 72.99 |
Other Long-Term Liabilities | 45.78 | 45.63 | 144.34 | 117.49 | 1,263 |
Total Liabilities | 9,680 | 10,279 | 12,107 | 11,482 | 20,001 |
Common Stock | 3,696 | 3,696 | 3,645 | 3,645 | 1,197 |
Additional Paid-In Capital | 7,520 | 7,520 | 6,925 | 35,611 | 5,883 |
Retained Earnings | 27,035 | 25,047 | 19,909 | -12,106 | -11,389 |
Treasury Stock | -2,996 | -2,996 | -2,996 | - | - |
Comprensive Income & Other | -1,045 | -1,045 | -615.82 | -447.54 | 881.74 |
Total Common Equity | 34,211 | 32,222 | 26,867 | 26,703 | -3,427 |
Minority Interest | 369.12 | 402.62 | -41.74 | -141.84 | - |
Shareholders' Equity | 34,580 | 32,625 | 26,826 | 26,561 | -725.76 |
Total Liabilities & Equity | 44,260 | 42,903 | 38,933 | 38,043 | 19,276 |
Total Debt | 6,667 | 7,318 | 9,201 | 8,089 | 2,688 |
Net Cash (Debt) | 5,877 | 1,238 | -628.38 | 5,669 | -1,437 |
Net Cash Per Share | 156.89 | 32.57 | -17.47 | 163.22 | -61.86 |
Filing Date Shares Outstanding | 35.47 | 35.47 | 34.97 | 36.45 | 3.72 |
Total Common Shares Outstanding | 35.47 | 35.47 | 34.97 | 36.45 | 3.72 |
Working Capital | 15,372 | 11,790 | 6,621 | 11,990 | -10,002 |
Book Value Per Share | 964.42 | 908.36 | 768.33 | 732.51 | -921.20 |
Tangible Book Value | 33,282 | 31,267 | 25,932 | 25,775 | -3,872 |
Tangible Book Value Per Share | 938.25 | 881.45 | 741.59 | 707.04 | -1040.73 |
Land | 5,550 | 5,550 | 5,340 | 3,582 | 3,549 |
Buildings | 6,258 | 7,248 | 6,942 | 3,417 | 3,325 |
Machinery | 3,918 | 8,673 | 7,686 | 6,510 | 5,359 |
Construction In Progress | 75 | 96.2 | 322.75 | 1,083 | 217.85 |
Source: S&P Capital IQ. Standard template. Financial Sources.